Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Delayed Data
As of Dec 02
 -2.85 / -0.76%
Today’s Change
Today|||52-Week Range
Jim Cramer's 'Mad Money' Recap: How to Handle Your Finances at Any Age
Dec 02 / TheStreet.com - Paid Partner Content
Celgene vs. Regeneron: Which Stock is a Better Pick?
Nov 29 / Zacks.com - Paid Partner Content
5 Top Performing Biotechnology Stocks of November
Dec 01 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzo...
Nov 23 / Zacks.com - Paid Partner Content
What Regeneron's CEO Thinks About Drug Pricing Under Trump
Dec 01 / TheStreet.com - Paid Partner Content
3 Biotechs That Don't Pay Dividends -- but Could
Nov 22 / MotleyFool.com - Paid Partner Content
Buy 7 Stocks with Impressive Interest Coverage Ratio
Dec 01 / Zacks.com - Paid Partner Content
Attention, Biotech Investors: Black Friday Is Already Here
Nov 21 / MotleyFool.com - Paid Partner Content
NVIDIA, Sotheby's Holdings, Celgene, Regeneron Pharmaceuticals and Sanofi highlighted...
Nov 30 / Zacks.com - Paid Partner Content
Wall Street rallies led by healthcare and banks
Nov 09 / FT.com - Paid Partner Content